Skip to search.
 FTSE 100 Up 0.32%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
21.60 Down 0.50(2.26%) 4 Aug 19:36
|Pre-Market : NaN
Add to Portfolio
Prev Close:22.10
Open:21.64
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:21.60 - 21.75
52wk Range:20.39 - 24.90
Volume:3,653
Avg Vol (3m):36,813
Market Cap:104.33b
P/E (ttm):6.65
EPS (ttm):3.25
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.25
P/S (ttm):2.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :75.72
Quarterly EPS Est (Sep-15) :19.96
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):3.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback